Ak. Rishi et al., REGULATION OF THE HUMAN RETINOIC ACID RECEPTOR-ALPHA GENE IN THE ESTROGEN-RECEPTOR NEGATIVE HUMAN BREAST-CARCINOMA CELL-LINES SKBR-3 AND MDA-MB-435, Cancer research, 56(22), 1996, pp. 5246-5252
Estradiol-mediated enhancement of retinoic acid receptor alpha (RAR al
pha) expression in the estrogen receptor (ER)-positive human breast ca
rcinoma (HBC) cells results in their sensitivity to RA-mediated growth
inhibition (A. K. Rishi et al., Cancer Res., 55: 4999-5006, 1995). Mo
st ER-negative HBCs are known to express lower levels of RAR alpha and
are resistant to RA-mediated inhibition of growth. We show that ER-ne
gative SKBR-3 and MDA-MB-435 HBCs express approximately 2-fold higher
levels of RAR alpha isoform 1 mRNA when compared to the ER-negative MD
A-MB-231 and MDA-MB-468 HBCs. SKBR-3 cells are sensitive to growth inh
ibition by RA, and by using RAR alpha-selective synthetic retinoids, w
e demonstrate that the antiproliferative effects of RA in the SKBR-3 c
ell line are accomplished, in part, via activation of RAR alpha. Both
MDA-MB-231 and MDA-MB-468 HBCs are not growth inhibited by RA or any o
f the retinoids tested. Transient transfection experiments using a 5.0
-kb RAR alpha promoter fragment fused to the luciferase reporter gene
showed 2-3-fold higher transcriptional activation in SKBR-3 cells when
compared to MDA-MB-468 cells. We report identification of a 72-bp fra
gment of RAR alpha promoter that contains unique cis elements responsi
ble for mediating an estradiol-independent 2.5-fold enhancement of RAR
alpha gene expression in SKBR-3 and MDA-MB-435 cells.